Skip to content

Long-term efficacy study of transurethral resection of bladder neck combined with regular triamcinolone acetonide injection for the treatment of bladder neck contracture after benign prostatic hyperplasia surgery

Long-term efficacy study of transurethral resection of bladder neck combined with triamcinolone acetonide injection for the treatment of bladder neck contracture after benign prostatic hyperplasia surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600121937
Enrollment
Unknown
Registered
2026-04-07
Start date
2026-04-15
Completion date
Unknown
Last updated
2026-04-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bladder neck contracture

Interventions

Regular Injection Group:None
Irregular/non-injection group:None

Sponsors

The First Affiliated Hospital of Xi'an Jiaotong University
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Age >= 18 years old; 2.Previously diagnosed with BPH and underwent transurethral prostate surgery; 3.Patients who were diagnosed with BNC via cystoscopy and underwent transurethral resection of bladder neck after surgery; 4.During the operation, the patient received triamcinolone acetonide injection therapy at the bladder neck; 40 mg/mL, 3mL, evenly injected into 8 points at the bladder neck; 5.Postoperative triamcinolone acetonide injection at bladder neck: Under local anesthesia, receive triamcinolone acetonide injection at the bladder neck; 6.Postoperative follow-up for at least 12 months.

Exclusion criteria

Exclusion criteria: 1.Those who have previously been diagnosed with urethral stricture and have undergone surgery for urethral stricture; 2.Combined severe urethral valve/urethral pseudotract; 3.The main outcome cannot be determined due to missing key data; 4.Participated in other clinical trials or used any experimental drugs within 30 days; 5.Other conditions that the researcher deems unsuitable for inclusion.

Design outcomes

Primary

MeasureTime frame
Bladder neck contracture recurrence rate;

Secondary

MeasureTime frame
Flow rate;International Prostate Symptom Score;Quality of life;Residual urine volume;

Countries

China

Contacts

Public ContactLin Yang

The First Affiliated Hospital of Xi'an Jiaotong University

docyanglin@126.com+86 189 9123 2334

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Apr 17, 2026